Literature DB >> 17347137

The role of PTEN in prostate cancer cell tropism to the bone micro-environment.

Z Wu1, K S McRoberts, D Theodorescu.   

Abstract

Little is known about the role of the tumor suppressor gene phosphatase and tensin homolog deleted on chromosome 10 (PTEN) in prostate cancer bone metastasis. To explore this, we used a pTetOn PTEN cell line in which PTEN expression was reconstituted in a PTEN-null bone metastatic human prostate cancer cell line, LnCaP-C4-2. We found that C4-2 cells selectively migrated toward conditioned medium from primary mouse calvaria cells compared with that derived from lung fibroblasts. Further evaluation with conditioned medium from an established mouse calvaria osteoblast cell line and control non-osteoblast cell line indicates that osteoblastic characteristics convey this specific migration to C4-2 cells. We evaluated promiscuously metastatic PC-3 prostate as well as T24T and UMUC-3 bladder cells and found they did not have a specific migratory response to calvaria-conditioned medium as did C4-2. Induction of PTEN expression inhibited the motility of C4-2 cells toward calvaria-conditioned medium but had no effect on migration toward lung-conditioned medium and this inhibitory effect was dependent on the PTEN lipid phosphatase activity. Calvaria- but not lung-conditioned medium induced activation of the small GTPase Rac1. Constitutively active Rac1 but not focal adhesion kinase or Cdc42 could rescue cells from the inhibitory effect of PTEN on cell migration and PTEN induction was observed to inhibit Rac1 activation in response to calvaria-conditioned medium. Our results support the notion that loss of PTEN function in human prostate cancer may specifically facilitate bone rather than other organ metastasis and suggest that Rac1, as a PTEN effector, may contribute to this metastatic tropism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17347137     DOI: 10.1093/carcin/bgm050

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  16 in total

1.  Loss of PTEN permits CXCR4-mediated tumorigenesis through ERK1/2 in prostate cancer cells.

Authors:  Mahandranauth A Chetram; Valerie Odero-Marah; Cimona V Hinton
Journal:  Mol Cancer Res       Date:  2010-11-12       Impact factor: 5.852

Review 2.  Integrins in prostate cancer progression.

Authors:  Hira Lal Goel; Jing Li; Sophia Kogan; Lucia R Languino
Journal:  Endocr Relat Cancer       Date:  2008-06-04       Impact factor: 5.678

Review 3.  Frequent gene products and molecular pathways altered in prostate cancer- and metastasis-initiating cells and their progenies and novel promising multitargeted therapies.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Mol Med       Date:  2011-05-20       Impact factor: 6.354

Review 4.  Prostate cancer: the need for biomarkers and new therapeutic targets.

Authors:  Juliana Felgueiras; Joana Vieira Silva; Margarida Fardilha
Journal:  J Zhejiang Univ Sci B       Date:  2014-01       Impact factor: 3.066

5.  Sonoporation delivery of interleukin-27 gene therapy efficiently reduces prostate tumor cell growth in vivo.

Authors:  Olga Zolochevska; Xueqing Xia; B Jill Williams; Alistair Ramsay; Shulin Li; Marxa L Figueiredo
Journal:  Hum Gene Ther       Date:  2011-09-01       Impact factor: 5.695

6.  Integrin α(v)β₃ as a PET imaging biomarker for osteoclast number in mouse models of negative and positive osteoclast regulation.

Authors:  Alexander Zheleznyak; Thaddeus J Wadas; Christopher D Sherman; Jessica M Wilson; Paul J Kostenuik; Katherine N Weilbaecher; Carolyn J Anderson
Journal:  Mol Imaging Biol       Date:  2012-08       Impact factor: 3.488

7.  Anticancer effect of deoxypodophyllotoxin induces apoptosis of human prostate cancer cells.

Authors:  Sheng Hu; Qiang Zhou; Wan-Rui Wu; Yi-Xing Duan; Zhi-Yong Gao; Yuan-Wei Li; Qiang Lu
Journal:  Oncol Lett       Date:  2016-08-03       Impact factor: 2.967

8.  Integrin signaling aberrations in prostate cancer.

Authors:  Hira Lal Goel; Naved Alam; Isaac N S Johnson; Lucia R Languino
Journal:  Am J Transl Res       Date:  2009-04-20       Impact factor: 4.060

9.  PI3Kp110-, Src-, FAK-dependent and DOCK2-independent migration and invasion of CXCL13-stimulated prostate cancer cells.

Authors:  Christelle P El Haibi; Praveen K Sharma; Rajesh Singh; Paul R Johnson; Jill Suttles; Shailesh Singh; James W Lillard
Journal:  Mol Cancer       Date:  2010-04-22       Impact factor: 27.401

10.  Gene network and canonical pathway analysis in prostate cancer: a microarray study.

Authors:  Hakan Savli; Attila Szendröi; Imre Romics; Balint Nagy
Journal:  Exp Mol Med       Date:  2008-04-30       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.